About US
Contact us
-
SFDA streamlines requirements for application dossiers of imported non-special purpose cosmeticsSFDA streamlines requirements for application dossiers of imported non-special purpose cosmetics In order to further simplify the requirements for application dossiers of imported non-special purp2010/11/25
-
FDA warning leads to decrease in antidepressant prescribing for young patientsFDA warning leads to decrease in antidepressant prescribing for young patients An FDA warning regarding increased suicide risk in children and teens taking antidepressant drugs has led to an overa2010/11/25
-
FDA grants Impax tentative approval for generic Cymbalta NDAFDA grants Impax tentative approval for generic Cymbalta NDA Impax Laboratories, Inc. (NASDAQ: IPXL) today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval2010/11/24
-
Par enters distribution agreement with AstraZeneca for generic AccolatePar enters distribution agreement with AstraZeneca for generic Accolate Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it has entered into an exclusive supply and distribution2010/11/24
-
BASF, the Micronutrient Initiative, and the UN Global Compact hosted event to address malnutrition for the world’s poorestBASF, the Micronutrient Initiative, and the UN Global Compact hosted event to address malnutrition for the world’s poorest Leaders from the private sector and international developmental agencies j2010/11/23
-
One Man’s OpinionOne Man’s Opinion API Max S. Lazar President FDA Regulatory Compliance Consulting BackgroundAfter 45 years in the drug and API industry, I have seen and experienced many things both as a member2010/11/23
-
FDA-approved anti-parasite drug blocks Wnt signaling pathway in colon cancerFDA-approved anti-parasite drug blocks Wnt signaling pathway in colon cancer Approved drug identified as inhibitor of Wnt signaling An old pinworm medicine is a new lead in the search for compoun2010/11/22
-
Vigor-25 contains hidden drug ingredient, warns FDAVigor-25 contains hidden drug ingredient, warns FDA FDA warns consumers not to use Vigor-25 Marketed as a 'male sexual stimulant,' product contains hidden drug ingredient The U.S. Food and Drug2010/11/22
-
New anti-cancer drug targeting vitamin D receptor reduces PSA level in HRPCNew anti-cancer drug targeting vitamin D receptor reduces PSA level in HRPC A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of2010/11/19
-
Sun Pharma receives FDA approval for generic Tiazac ANDASun Pharma receives FDA approval for generic Tiazac ANDA Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE:SUNPHARMA, BSE: 524715) announced that USFDA has granted its s2010/11/19